These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3461747

  • 1. [A phase II study of epirubicin in malignant lymphoma].
    Masaoka T, Shibata H, Sampi K, Hirota Y, Yoshida Y, Chiba Y, Shirakawa S, Kobayashi T, Toki H, Tamura K.
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2606-11. PubMed ID: 3461747
    [Abstract] [Full Text] [Related]

  • 2. [Phase II study of epirubicin on breast cancer: a cooperative group study].
    Tominaga T, Kitamura M, Nomura Y, Abe O, Enomoto K, Ikeda T, Izuo M, Iino Y, Taguchi T, Tamura K.
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2187-92. PubMed ID: 3459397
    [Abstract] [Full Text] [Related]

  • 3. [Phase II study of epirubicin in inoperable or recurrent gastric cancer].
    Sakata Y, Yoshida Y.
    Gan To Kagaku Ryoho; 1986 May; 13(5):1887-92. PubMed ID: 3458431
    [Abstract] [Full Text] [Related]

  • 4. [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
    Kimura K, Suga S, Kano H, Sakakibara K, Hayashi T, Nakai T, Nagano I, Yokoyama Y, Morise K, Hayakawa M.
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2440-5. PubMed ID: 3460530
    [Abstract] [Full Text] [Related]

  • 5. [A phase I study of 4'-epi-adriamycin, a new anthracycline anticancer agent].
    Kimura K, Wakui A, Saito T, Tominaga T, Niitani H, Fujimoto T, Masaoka T, Toki H, Tamura K.
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2414-9. PubMed ID: 6594078
    [Abstract] [Full Text] [Related]

  • 6. Phase I-II trial of high-dose epirubicin in patients with lymphoma.
    Case DC, Gams R, Ervin TJ, Boyd MA, Oldham FB.
    Cancer Res; 1987 Dec 01; 47(23):6393-6. PubMed ID: 3479245
    [Abstract] [Full Text] [Related]

  • 7. A phase II study of epirubicin in acute leukemia: a cooperative group study.
    Sampi K, Masaoka T, Shirakawa S, Shirai T, Abe T, Shibata H, Umeda M, Kobayashi T, Sugiyama H, Toki H.
    Anticancer Res; 1987 Dec 01; 7(1):29-31. PubMed ID: 3471173
    [Abstract] [Full Text] [Related]

  • 8. [A phase II study of epirubicin in acute leukemia: a cooperative group study].
    Sampi K, Masaoka T, Shibata H, Shirakawa S, Kobayashi T, Shirai T, Umeda M, Kozuru M, Sugiyama H, Oguro M.
    Gan To Kagaku Ryoho; 1986 Aug 01; 13(8):2594-9. PubMed ID: 3461746
    [Abstract] [Full Text] [Related]

  • 9. [Cooperative phase II study of epirubicin (EPI) in bladder cancer, renal pelvic and ureteral tumors--Urological Cooperative Study Group of EPI].
    Niijima T, Koyanagi T, Maru A, Sakashita S, Koiso K, Ishikawa H, Uchida K, Shimazaki J, Isaka S, Akaza H.
    Hinyokika Kiyo; 1986 Sep 01; 32(9):1359-69. PubMed ID: 3468792
    [Abstract] [Full Text] [Related]

  • 10. [A phase II study of mitoxantrone in refractory and relapsed malignant lymphomas. Cooperative Study Group of Mitoxantrone in Malignant Lymphomas].
    Kimura I, Ohnoshi T, Ogawa M, Sampi K, Masaoka T, Yamada K, Ohta K, Kitani T, Kawagoe H, Shirakawa S.
    Gan To Kagaku Ryoho; 1986 Sep 01; 13(9):2800-6. PubMed ID: 3753026
    [Abstract] [Full Text] [Related]

  • 11. [Late phase II clinical study of amrubicin hydrochloride, a novel synthetic anthracycline derivative anticancer agent, for malignant lymphoma].
    Akutsu M, Kano Y, Ogawa M, Miura A, Hirano M, Masaoka T, Tatsumi N.
    Gan To Kagaku Ryoho; 2001 Nov 01; 28(12):1867-76. PubMed ID: 11729479
    [Abstract] [Full Text] [Related]

  • 12. [A phase II study of epirubicin in advanced lung cancer].
    Furuse K, Fukuoka M, Yamamoto M, Kawahara M, Tsuruta M, Kodama N, Arai R, Hayashi S, Kiyota M, Kubota K.
    Gan To Kagaku Ryoho; 1986 Sep 01; 13(9):2835-40. PubMed ID: 3019252
    [Abstract] [Full Text] [Related]

  • 13. [Effects of single administration of tetrahydropyranyladriamycin (THP) in lymphoid malignancy].
    Takagi T, Oguro M, Iwabuchi K.
    Gan To Kagaku Ryoho; 1984 Jul 01; 11(7):1450-6. PubMed ID: 6588924
    [Abstract] [Full Text] [Related]

  • 14. A phase of I trial of 4'-epi-Adriamycin.
    Schauer PK, Wittes RE, Gralla RJ, Casper ES, Young CW.
    Cancer Clin Trials; 1981 Jul 01; 4(4):433-7. PubMed ID: 7318126
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Phase II study of 4'-O-tetrahydropyranyladriamycin(THP-ADM)].
    Nakada H, Ogawa M, Miyamoto H, Inagaki J, Horikoshi N, Inoue K, Ikeda K, Usui N, Adachi K, Okada Y.
    Gan To Kagaku Ryoho; 1984 Jan 01; 11(1):138-42. PubMed ID: 6696455
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Early phase II clinical trial of amrubicin hydrochloride in patients with malignant lymphoma].
    Masaoka T, Ogawa M, Inoue K, Sanpi K, Kuraishi Y, Toki H, Tamura K, Takagi T, Shibata A, Hirano M, Ezaki K, Shirakawa S, Matsuda T, Kimura I.
    Gan To Kagaku Ryoho; 2001 Nov 01; 28(12):1857-65. PubMed ID: 11729478
    [Abstract] [Full Text] [Related]

  • 19. [Phase II study of (2''R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with solid tumors. Multi-Institutional Cooperative Study].
    Saito T, Kasai Y, Wakui A, Furue H, Majima H, Nitani H, Niijima T, Takeda C, Abe O, Koyama Y.
    Gan To Kagaku Ryoho; 1986 Apr 01; 13(4 Pt 1):1060-9. PubMed ID: 3963850
    [Abstract] [Full Text] [Related]

  • 20. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Apr 01; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.